{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T08:15:55Z","timestamp":1762157755254},"publisher-location":"Berlin, Heidelberg","reference-count":23,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783662578797"},{"type":"electronic","value":"9783662578803"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/8904_2017_62","type":"book-chapter","created":{"date-parts":[[2017,9,23]],"date-time":"2017-09-23T02:16:04Z","timestamp":1506132964000},"page":"31-37","source":"Crossref","is-referenced-by-count":20,"title":["Asymptomatic Corneal Keratopathy Secondary to Hypertyrosinaemia Following Low Dose Nitisinone and a Literature Review of Tyrosine Keratopathy in Alkaptonuria"],"prefix":"10.1007","author":[{"given":"M.","family":"Khedr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Judd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. C.","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. T.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Milan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. M. K.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. A.","family":"Lock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. R.","family":"Ranganath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,24]]},"reference":[{"key":"62_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1023\/A:1024011110116","volume":"26","author":"P Gissen","year":"2003","unstructured":"Gissen P, Preece M, Willshaw H, McKiernan PJ (2003) Ophthalmic follow-up of patients with tyrosinaemia type I on NTBC. J Inherit Metab Dis 26:13\u201316","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"62_CR2","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1023\/A:1005410820201","volume":"21","author":"E Holme","year":"1998","unstructured":"Holme E, Lindstedt S (1998) Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione). J Inherit Metab Dis 21(5):507\u2013517","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"62_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ymgme.2011.04.016","volume":"103","author":"WJ Introne","year":"2011","unstructured":"Introne WJ, Perry MB, Troendle J et al (2011) A 3-year randomized therapeutic trial of nitisinone in alkaptonuria. Mol Genet Metab 103(4):307\u2013314","journal-title":"Mol Genet Metab"},{"key":"62_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/8904_2015_437","volume":"24","author":"CM Keenan","year":"2015","unstructured":"Keenan CM, Preston AJ, Sutherland H et al (2015) Nitisinone arrests but does not reverse Ochronosis in Alkaptonuric mice. JIMD Rep 24:45\u201350","journal-title":"JIMD Rep"},{"issue":"10","key":"62_CR5","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1097\/ICO.0000000000000226","volume":"33","author":"S Kocabeyoglu","year":"2014","unstructured":"Kocabeyoglu S, Mocan MC, Irkec M (2014) In vivo confocal microscopic features of corneal pseudodendritic lesions in tyrosinemia type II. Cornea 33(10):1106\u20131108","journal-title":"Cornea"},{"key":"62_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1006\/taap.1996.0310","volume":"141","author":"EA Lock","year":"1996","unstructured":"Lock EA, Gaskin P, Ellis MK et al (1996) Tissue distribution of 2-(2-Nitro-4-trifluoromethylbenzoyl)cyclohexane-1,3-dione (NTBC): effect on enzymes involved in tyrosine catabolism and relevance to ocular toxicity in the rat. Toxicol Appl Pharmacol 141:439\u2013447","journal-title":"Toxicol Appl Pharmacol"},{"key":"62_CR7","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1023\/A:1005458703363","volume":"21","author":"EA Lock","year":"1998","unstructured":"Lock EA, Ellis MK, Gaskin P et al (1998) From toxicological problem to therapeutic use: the discovery of the mode of action of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC), its toxicology and development as a drug. J Inherit Metab Dis 21:498\u2013506","journal-title":"J Inherit Metab Dis"},{"key":"62_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.taap.2006.01.015","volume":"215","author":"EA Lock","year":"2006","unstructured":"Lock EA, Gaskin P, Ellis M, Provan WM, Smith LL (2006) Tyrosinaemia produced by 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione (NTBC) in experimental animals and its relationship to corneal injury. Toxicol Appl Pharmacol 215:9\u201316","journal-title":"Toxicol Appl Pharmacol"},{"key":"62_CR9","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1525-1470.2008.00687.x","volume":"25","author":"T Meissner","year":"2008","unstructured":"Meissner T, Betz RC, Pasternak SM et al (2008) Richner-Hanhart syndrome detected by expanded newborn screening. Paediatr Dermatol 25:378\u2013380","journal-title":"Paediatr Dermatol"},{"key":"62_CR10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1177\/0004563217691065","volume":"54","author":"AM Milan","year":"2017","unstructured":"Milan AM, Hughes AT, Davison AS et al (2017) The effect of nitisinone on homogentisic acid and tyrosine: a two-year survey of patients attending the National Alkaptonuria Centre, Liverpool. Ann Clin Biochem 54:323\u2013330","journal-title":"Ann Clin Biochem"},{"key":"62_CR11","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0014-4835(03)00050-2","volume":"76","author":"LJ Muller","year":"2003","unstructured":"Muller LJ, Marfurtb CF, Krusec F, Tervod TM (2003) Corneal nerves: structure, contents and function. Exp Eye Res 76:521\u2013542","journal-title":"Exp Eye Res"},{"key":"62_CR12","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/0002-9343(63)90089-5","volume":"34","author":"WM O\u2019Brien","year":"1963","unstructured":"O\u2019Brien WM, BNL D, Bunim JJ (1963) Biochemical, pathologic and clinical aspects of alcaptonuria, ochronosis and ochronotic arthropathy. Am J Med 34:813\u2013838","journal-title":"Am J Med"},{"key":"62_CR13","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1056\/NEJMoa021736","volume":"347","author":"C Phornphutkul","year":"2002","unstructured":"Phornphutkul C, Introne WJ, Perry MB et al (2002) Natural history of alkaptonuria. N Engl J Med 347:2111\u20132121","journal-title":"N Engl J Med"},{"issue":"1","key":"62_CR14","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1136\/annrheumdis-2012-202878","volume":"73","author":"AJ Preston","year":"2014","unstructured":"Preston AJ, Keenan CM, Sutherland H et al (2014) Ochronotic osteoarthropathy in a mouse model of alkaptonuria, and its inhibition by nitisinone. Ann Rheum Dis 73(1):284\u2013289","journal-title":"Ann Rheum Dis"},{"key":"62_CR15","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1136\/jclinpath-2012-200877","volume":"66","author":"LR Ranganath","year":"2013","unstructured":"Ranganath LR, Jarvis JC, Gallagher JA (2013) Recent advances in management of alkaptonuria (invited review; best practice article). J Clin Pathol 66:367\u2013373","journal-title":"J Clin Pathol"},{"key":"62_CR16","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s10545-015-9888-7","volume":"38","author":"LR Ranganath","year":"2015","unstructured":"Ranganath LR, Timmis OG, Gallagher JA (2015) Progress in alkaptonuria \u2013 are we near to an effective therapy? J Inherit Metab Dis 38:787\u2013789","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"62_CR17","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/annrheumdis-2014-206033","volume":"75","author":"LR Ranganath","year":"2016","unstructured":"Ranganath LR, Milan AM, Hughes AT et al (2016) Suitability of nitisinone in alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallelgroup, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment. Ann Rheum Dis 75(2):362\u2013367","journal-title":"Ann Rheum Dis"},{"key":"62_CR18","first-page":"571","volume":"8","author":"M Sacchetti","year":"2014","unstructured":"Sacchetti M, Lambiase A (2014) Diagnosis and management of neurotrophic keratitis. Clin Ophthalmol 8:571\u2013579","journal-title":"Clin Ophthalmol"},{"key":"62_CR19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/jcp.25082","volume":"231","author":"M Sacchetti","year":"2016","unstructured":"Sacchetti M, Macchi I, Tiezzi A, La Cava M, Massaro-Giordano G, Lambiase A (2016) Pathophysiology of corneal dystrophies: from cellular genetic alteration to clinical findings. J Cell Physiol 231:261\u2013269","journal-title":"J Cell Physiol"},{"issue":"1","key":"62_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/ICO.0b013e318243e474","volume":"32","author":"P-P Schauwvlieghe","year":"2013","unstructured":"Schauwvlieghe P-P, Jaeken J, Kestelyn P, Claerhout I (2013) Confocal microscopy of corneal crystals in a patient with hereditary tyrosinemia type I, treated with NTBC. Cornea 32(1):91\u201394","journal-title":"Cornea"},{"issue":"3","key":"62_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.survophthal.2013.09.002","volume":"59","author":"B Shaheen","year":"2014","unstructured":"Shaheen B, Bakir M, Jain S (2014) Corneal nerves in health and disease. Surv Ophthalmol 59(3):263\u2013285","journal-title":"Surv Ophthalmol"},{"key":"62_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/8904_2014_307","volume":"17","author":"R Stewart","year":"2014","unstructured":"Stewart R, Briggs MC, Jarvis JC et al (2014) Reversible keratopathy due to hypertyrosinaemia following intermittent low-dose nitisinone in alkaptonuria: a case report. JIMD Rep 17:1\u20136","journal-title":"JIMD Rep"},{"key":"62_CR23","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/0304-4165(69)90068-3","volume":"177","author":"VG Zannoni","year":"1969","unstructured":"Zannoni VG, Lomtevas N, Goldfinger S (1969) Oxidation of homogentisic acid to ochronotic pigment in connective tissue. Biochim Biophys Acta 177:94\u2013105","journal-title":"Biochim Biophys Acta"}],"container-title":["JIMD Reports","JIMD Reports, Volume 40"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/8904_2017_62","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T14:58:15Z","timestamp":1557500295000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/8904_2017_62"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783662578797","9783662578803"],"references-count":23,"URL":"https:\/\/doi.org\/10.1007\/8904_2017_62","relation":{},"ISSN":["2192-8304","2192-8312"],"issn-type":[{"type":"print","value":"2192-8304"},{"type":"electronic","value":"2192-8312"}],"subject":[],"published":{"date-parts":[[2017]]}}}